Gainers
Entera Bio Ltd. (NASDAQ: ENTX) shares surged 44.8% to close at $6.50 on Wednesday after the company reported topline Phase 2 bone mineral density data for EB613.
With the coronavirus changing the world in 2020, it makes sense that there’s a spotlight on science to prevent viruses from growing into pandemics. While Pfizer (NYSE: PFE) and Moderna Inc.
Nanoviricides (AMEX:NNVC) reported quarterly losses of $(0.19) per share. This is a 84.68 percent increase over losses of $(1.24) per share from the same period last year.